Bruker BioSciences, Sigma-Aldrich, Manchester University, NIEHS, FDA | GenomeWeb

Bruker Says 'Material Weakness' at Subsidiary
Will Force Firm to Raise 2004 Losses

A "material weakness in internal controls" at an undisclosed Bruker BioSciences subsidiary will cause Bruker to increase its 2004 net losses, the company said.

According to a statement released Wednesday, Bruker said it has been made aware of several 2004 audit adjustments that it said will have a negative impact on its 2004 financial results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.